Repository logo
 
Loading...
Thumbnail Image
Publication

Non-viral strategies for ocular gene delivery

Use this identifier to reference this record.
Name:Description:Size:Format: 
1-s2.0-S0928493117309827-main.pdf1013.97 KBAdobe PDF Download

Advisor(s)

Abstract(s)

The success of gene therapy relies on efficient gene transfer and stable transgene expression. The in vivo efficiency is determined by the delivery vector, route of administration, therapeutic gene, and target cells. While some requirements are common to several strategies, others depend on the target disease and transgene product. Consequently, it is unlikely that a single system is suitable for all applications. This review examines current gene therapy strategies, focusing on non-viral approaches and the use of natural polymers with the eye, and particularly the retina, as their gene delivery target. (C) 2017 Elsevier B.V. All rights reserved.

Description

Keywords

Retinal-pigment epithelium Hyaluronic-acid In-vivo Biomedical applications Plasmid Dna Chitosan nanoparticles Drug-delivery Transfection efficiency Magnetic nanoparticles Neurotrophic factor

Citation

Organizational Units

Journal Issue

Publisher

Elsevier

CC License

Altmetrics